We improve diagnosis, prognosis and treatment of cancer
Patients should only undergo medical procedures that are meaningful and necessary. No woman should have unjustified worries about getting cervical cancer and every cancer patient is taken care off with effective treatment protocols only.
Patient oriented
Personalizing diagnosis and prognosis is paramount to us.
Cooperative & efficient
We listen to patients and communicate with doctors to provide them with best possible treatment suggestions.
Reliable & objective
Predica provides objective treatment suggestions based on computer algorithms with proven value.
Our mission:
To prevent overdiagnosis and overtreatment of cancer by predicting the best treatment for cancer patients.
Learn how Predica Diagnostics accomplishes this by checking our technology
Our Products
Predica Diagnostics BV uses the proprietary ciRNAseq technology. The CervicaDX assay, based on this technology, will be developed and marketed to non-invasively assess the risk to develop cervical cancer and to guide proper treatment.
Our first product, the CervicaDx test, will prevent overdiagnosis and overtreatment of women, participating in cervical cancer screening programs, by detecting cervical aberrations before they can develop into cancer, with much higher specificity than is currently feasible.
